Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec appointment
confidence 75%
filed 2026-07-23
The filing discloses two distinct executive events under Item 5.02: (1) appointment of David Allen to the Board of Directors and as Chair of the Audit Committee, and (2) approval of an employment agreement with Mark Heinen (CFO) including base salary, bonus structure, and severance terms. While both events are material, the appointment of a new independent director to the board and audit committee chair position is the primary disclosed action, making exec_appointment the most salient classification. The compensation arrangement with Heinen is secondary and supportive of the leadership continuity narrative.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-23
Item 8.01
The filing discloses the closing of a material disposition: Canton Strategic Holdings sold 100% of the membership interests in Gravitas Life Sciences, LLC to Gravitas Collective Corp. on July 17, 2026. The transaction involved a $3.5 million unsecured promissory note and contingent milestone payments. The pro forma financial statements show the divestiture eliminated Gravitas's R&D operations and reduced the company's operating expenses significantly, reflecting a substantial change in the company's asset base and business composition. This is a completed material acquisition/disposition event requiring 8-K disclosure under Item 1.02 or 2.01 framework.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-23
SINTX announced engagement of Southern Metrics Consulting to establish a Strategic Opportunity Management Program to identify and evaluate strategic opportunities including partnerships, licensing, investments, joint ventures, acquisitions, and divestitures. This is a material operational/strategic initiative signaling the company's transition toward commercialization and potential M&A activity, but the disclosure itself is about establishing a process rather than announcing a specific transaction or material event that fits a more specific category.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-07-23
EX-99.1
Real Messenger received a Nasdaq notification letter dated July 22, 2026, stating that the Company failed to maintain the minimum closing bid price of $1 per share for 30 consecutive business days, triggering Nasdaq Listing Rule 5550(a)(2) deficiency. While the letter does not result in immediate delisting, the Company has 180 calendar days (until January 19, 2027) to regain compliance or face potential delisting. The disclosure explicitly states that "if the Company does not regain compliance by January 19, 2027... Nasdaq will provide notice that its securities will be subject to delisting," and acknowledges "there can be no assurance that the Company will be able to timely regain or maintain compliance." This is a material delisting-risk disclosure under Item 3.01 equivalent.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-07-23
The 8-K discloses the Board's approval of the 2026 Annual General Meeting of Shareholders scheduled for August 24, 2026, along with the notice, proxy statement, and proxy card. The meeting agenda includes director elections (including one new independent director nominee, Jialin Li, as successor to Peter Nobel, and an additional director, Gregory McGillis), auditor ratification, authorization to increase authorized share capital from 1 billion to 20 billion shares, and authorization for reverse stock splits up to 4,000:1 aggregate ratio. While the filing is Item 8.01 (Other Events) rather than a dedicated governance item, the substance is clearly a shareholder meeting notice with multiple material governance and capital structure proposals. The authorization for up to 4,000:1 reverse splits and 19 billion additional authorized shares are particularly material to investors assessing dilution and capital structure risk.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-07-23
FatPipe disclosed a recently filed Form S-3 registration statement and an at-the-market (ATM) offering program. The CEO's letter explicitly states the company has "not issued nor sold any shares" under the ATM to date, but the registration statement provides the legal framework for future dilutive equity issuances. The disclosure of an ATM program is material to investors as it signals potential future dilution and capital-raising activity, even though no shares have yet been issued. This is a forward-looking disclosure of dilutive issuance capability.
View raw filing on EDGAR →
6-K
Workforce Reduction
confidence 92%
filed 2026-07-23
EX-99.1
The announcement discloses a strategic reorganisation effective 1 January 2027 involving a global workforce reduction of approximately 10%-20%, headquarters relocation to the U.S., and operational restructuring. The filing explicitly states this "reflects a necessary realignment of operating expenditure with current revenue generation and near-term clinical and commercial priorities." This is a material operational restructuring with workforce reduction, the hallmark of Item 2.05 disclosure, and would affect a reasonable investor's assessment of the company's cost structure and operational footprint.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-23
The filing discloses under Item 8.01 that the Board authorized and declared monthly dividend payments on Series A Preferred Stock ($4.791 per share) and Series 1 Preferred Stock ($4.583 per share), payable on or about August 12, 2026. This is a clear dividend distribution event. The materiality is high given the specific per-share amounts and the fact that preferred stock dividends are typically material to investors holding those securities.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-07-23
The filing discloses entry into a Loan Assignment and Share Repurchase Agreement under Item 1.01, whereby Crisp Momentum assigned its $1.5 million outstanding loan to Partum AG in exchange for Partum transferring 20 million shares back to the Company. This is a material financial transaction involving both debt assignment and equity repurchase, but does not fit neatly into the specific categories of debt_issuance (no new debt created), ma_activity (not an acquisition or merger), or dilutive_issuance (shares are being repurchased, not issued). The transaction materially affects the Company's capital structure and is best classified as a financial event outside the named categories.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-23
The filing discloses that Mr. Nilay Patel, the Chief Legal Officer, will no longer serve as an officer of Cingulate Inc. effective August 3, 2026, due to the Board's decision to eliminate the Chief Legal Officer position. This is a departure of a named executive officer, treated as a termination without cause under his employment agreement. The elimination of a C-suite legal function is material to investors' assessment of the company's governance and operational structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-07-23
Eva Live Inc entered into a securities purchase agreement to issue a $2.16 million secured convertible note with an 8% original issue discount, convertible into common stock at 87% of the 10-day VWAP (floor price $0.472). The filing explicitly discloses this under Item 3.02 (Unregistered Sales of Equity Securities) and Item 1.01 (Material Definitive Agreement), with conversion shares registered on the company's Form S-3. This is a dilutive equity issuance raising capital through convertible debt, a material financing event for a small-cap company.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-23
The filing discloses results of Syra Health Corp.'s Annual Meeting of Stockholders held on July 23, 2026, under Item 5.07. The document presents voting results for three proposals: election of five directors, ratification of M&K CPAs as independent auditor, and approval of an amendment to the 2022 Omnibus Equity Incentive Plan increasing available Class A shares to 4,100,000. This is a standard shareholder vote results disclosure material to investors assessing governance and capital structure decisions.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-07-23
XMax Inc.'s subsidiary Xmax Beta Holdings Ltd. entered into a Subscription Agreement on July 17, 2026, investing $8.32 million to increase its interest in Preamble X Capital I to over 99.9%, which then subscribed for approximately 48% interests in a private investment fund for $8 million with the intent to invest substantially all assets in Figure AI Inc. stock. This represents a material acquisition of an investment interest and constitutes a significant capital deployment that would affect investor assessment of the registrant's financial position and strategic direction.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-23
Item 1.01
Item 1.01 discloses Ocean Power Technologies' acquisition of intellectual property assets from Columbia Power Technologies, Inc. for $2.9 million in stock consideration (10,984,848 shares). The acquisition expands OPT's operational infrastructure portfolio with subsea power technology capabilities, representing a material strategic transaction that would affect investor assessment of the company's technology portfolio and competitive positioning.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-23
The filing discloses completion of cybersecurity and software remediation for an FDA 510(k) submission, with the company on track to submit in H2 2026. This is a material operational and regulatory milestone for a medical device company seeking FDA clearance to enter the U.S. market, representing de-risking of the regulatory pathway. While not fitting a specific named event type, this is clearly an operational/strategic milestone that would affect investor assessment of the company's progress toward commercialization.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-23
Item 5.02
The filing discloses both a director resignation (Michael Kosloske) and the appointment of a new director (Zebulon Z. Hadley, IV) to fill the vacancy. While both events are present, the principal action emphasized in the disclosure is the appointment of Hadley, including detailed biographical information, his appointment as Chair of the Compensation Committee, and confirmation of standard director compensation arrangements. The appointment of a new board member with significant business credentials and committee leadership is the salient event for investors.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-07-23
InspireMD received a notice from Nasdaq on July 17, 2026 that it failed to maintain the minimum bid price of $1.00 per share required under Nasdaq Listing Rule 5550(a)(2). The company has been given a 180-day compliance period until January 13, 2027 to regain compliance, with the explicit warning that failure to do so could result in delisting. This is a classic delisting-risk disclosure under Item 3.01.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-23
The filing discloses the completion of a material business combination on July 17, 2026, in which FG Merger II Corp. (FGMC) merged with BOXABL Inc., with BOXABL surviving as a subsidiary and then merging into FGMC, which was renamed BOXABL Inc. The transaction involved the issuance of 246.5 million shares of common stock and 103.5 million shares of preferred stock valued at $3.5 billion to BOXABL securityholders. This is a classic change-of-control transaction disclosed under Item 2.01 (Completion of Acquisition or Disposition of Assets) and Item 1.01 (Entry into Material Definitive Agreement).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-23
The filing discloses results of the 2026 Annual Meeting of Stockholders held on July 23, 2026, with detailed voting outcomes for eight proposals including charter amendments establishing a classified board, director elections, auditor ratification, say-on-pay votes, and approval of an amended equity incentive plan. Item 5.07 explicitly reports shareholder vote results, which is the primary disclosure focus of this 8-K.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-07-23
EX-99.1
Almonty announces its voluntary delisting from the Australian Securities Exchange (ASX), effective September 1, 2026. The company cites low and declining trading volumes (CDIs representing only 0.80% of issued shares as of July 14, 2026) and the burden of maintaining ASX listing compliance. This is a material disclosure of delisting that directly affects shareholders' ability to trade on ASX and requires conversion or sale of CDIs through specified facilities.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-23
Item 2.02
Bankwell Financial Group disclosed second quarter 2026 results with GAAP net income of $12.4 million ($1.52 per share), net interest income of $29.5 million, and updated full-year 2026 guidance for net interest income ($115–$117 million), loan growth (5–7%), and non-interest expenses ($65–$67 million). The earnings release was furnished as Exhibit 99.1 and accompanied by a slide presentation on financial results and trends through June 30, 2026.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-23
Item 8.01
The Board of Directors declared a quarterly dividend of $0.20 per share, payable on August 21, 2026 to shareholders of record as of August 10, 2026.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-23
Item 5.02
The disclosure centers on compensatory arrangements for Robert Rasmus, the President, CEO, and director. The Amendment modifies his salary to $50,000, eliminates bonus and long-term incentive eligibility, and authorizes grants of 600,000 time-based RSUs and 600,000 performance-based RSUs under the 2026 Omnibus Incentive Plan, plus an extension of 400,000 inducement RSUs. These are material equity and cash compensation modifications that would affect investor assessment of executive pay and incentive alignment.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-23
Item 2.02
HomeTrust Bancshares issued a press release on July 23, 2026 reporting preliminary net income of $15.6 million for Q2 2026 (diluted EPS of $0.94) and declared a quarterly cash dividend of $0.15 per share, along with detailed financial metrics and year-over-year comparisons.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-07-23
Item 8.01
The filing explicitly states "This current report on Form 8-K relates to a distribution made to holders of the Certificates issued by the Select Notes Trust LT 2003-1." This is a distribution to certificate holders of a structured trust vehicle. While the prose is largely boilerplate disclosure about underlying security issuers and SEC reporting requirements, the core event is the distribution itself. For a structured trust, distributions to certificate holders constitute dividend_distribution or similar capital distribution events material to investors in the trust certificates.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-07-23
Item 8.01
The filing explicitly states it "relates to a distribution made to holders of the Certificates issued by the Select Notes Trust LT 2003-2." This is a distribution to security holders of a structured trust vehicle. While the prose is largely boilerplate disclosure about underlying issuers' reporting obligations, the core event disclosed is a distribution to certificate holders, which falls under dividend_distribution. The materiality is high for investors in this trust instrument, as distributions are a primary economic return mechanism.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-07-23
Item 8.01
The filing explicitly states "This current report on Form 8-K relates to a distribution made to holders of the Certificates issued by the Select Notes Trust LT 2003-3." This is a distribution to certificate holders, which constitutes a dividend or distribution event. While the prose is largely boilerplate disclosure about underlying securities and SEC reporting requirements, the core event disclosed is the distribution itself, making this a dividend_distribution classification.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-07-23
Item 8.01
The filing explicitly states "This current report on Form 8-K relates to a distribution made to holders of the Certificates issued by the Select Notes Trust LT 2003-4." This is a distribution to certificate holders, which falls within the dividend_distribution category. While the disclosure is sparse on details, the core event is the announcement of a distribution payment to security holders of this structured product trust.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-07-23
Item 8.01
The filing explicitly states "This current report on Form 8-K relates to a distribution made to holders of the Certificates issued by the Select Notes Trust LT 2003-5." This is a distribution to certificate holders, which falls within the dividend_distribution category. While the disclosure is sparse on details, the core event is a distribution to security holders of a structured product trust.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-23
Item 1.01
Five Star Bancorp entered into an underwriting agreement on July 22, 2026 to issue and sell 2,725,000 shares of common stock at $44.00 per share in a registered public offering, with expected net proceeds of approximately $112.9–$113.6 million. Underwriters received a 30-day option to purchase an additional 408,750 shares, further increasing dilution potential.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-23
Item 7.01
The Board of Directors declared a regular quarterly cash dividend of $0.05 per share on July 23, 2026, payable on September 4, 2026 to stockholders of record as of August 3, 2026. This is a straightforward dividend declaration that would be material to investors as it represents a return of capital and signals management's confidence in cash generation and capital allocation policy.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-07-23
Item 2.02
USCB Financial Holdings issued a press release on July 23, 2026 announcing Q2 2026 quarterly financial results for the period ended June 30, 2026, reporting net income of $9.1 million ($0.49 per diluted share), a 3.49% net interest margin, 1.26% ROAA, and 15.90% ROAE, along with balance sheet metrics showing assets surpassing $3 billion.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-07-23
Item 8.01
News Corporation is disclosing daily buy-back notifications under its $1 billion repurchase program authorized as of July 15, 2025. The Item 8.01 disclosure reports that the company has purchased approximately US$383.2 million worth of Class A and Class B shares to date, with recent transactions totaling US$249.3 million across both classes. Share repurchase programs are a form of capital return to shareholders and fall within the dividend_distribution taxonomy as a return of capital, distinct from operational or governance matters.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-23
Item 2.02
Rexford Industrial issued a press release on July 23, 2026 announcing its financial and operating results for the second quarter ended June 30, 2026, including net loss of $506.9 million per diluted share, Core FFO of $0.63 per diluted share, and updated 2026 guidance. The disclosure includes material operational metrics and strategic announcements including a portfolio realignment with $1.5–$2.0 billion in planned dispositions, raised Core FFO guidance, and a new $1.0 billion share repurchase authorization.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-23
Item 2.02
Five Point Holdings issued a press release on July 23, 2026 announcing its second quarter 2026 results of operations, including consolidated revenues of $13.9 million, consolidated net income of $29.9 million, and detailed segment performance. The filing explicitly states "On July 23, 2026, Five Point Holdings, LLC issued a press release announcing its results of operations for the three months ended June 30, 2026" under Item 2.02, with the press release furnished as Exhibit 99.1. This is a standard quarterly earnings disclosure with financial statements and management commentary.
View raw filing on EDGAR →
6-K
Auditor Change
confidence 98%
filed 2026-07-23
The 6-K discloses a change in the Company's Independent Registered Public Accounting Firm from Ernst & Young Associates LLP to Deloitte Haskins & Sells, LLP, approved by the Board on July 22, 2026. The filing explicitly states that Deloitte will audit the Company's Form 20-F and review interim 6-K filings, replacing EY who completed the audit for the year ended March 31, 2026. This is a clear auditor change under Item 16F of Form 20-F, material to investors assessing financial reporting reliability.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-23
EX-99.1
This exhibit discloses the outcome and voting results of Dr. Reddy's 42nd Annual General Meeting held on July 23, 2026, including the Scrutinizer's Report on remote e-voting and e-voting during the AGM, and agenda-wise voting details. Seven resolutions were voted on and declared passed by requisite majority, including adoption of audited financial statements, declaration of dividend, director re-appointments and appointments, auditor appointment, and cost auditor remuneration ratification. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-23
EX-99.1
This exhibit discloses the results of shareholder votes at Dr. Reddy's 42nd Annual General Meeting held on July 23, 2026. The members approved three resolutions: (1) re-appointment of Dr. K P Krishnan as an Independent Director for a second five-year term; (2) appointment of Mr. Srikanth Velamakanni as an Independent Director; and (3) appointment of Deloitte Haskins & Sells, LLP as Statutory Auditors. These are material governance matters affecting board composition and audit oversight, disclosed under Regulation 30 of the SEBI Listing Regulations.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-23
Item 2.02
Ladder Capital Corp issued a press release on July 23, 2026 disclosing financial results for the quarter ended June 30, 2026, reporting GAAP income before taxes of $16.3 million ($0.12 diluted EPS) and distributable earnings of $30.8 million ($0.24 distributable EPS). The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the earnings release furnished as Exhibit 99.1, which is the standard format for quarterly earnings disclosures.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-23
Item 2.02
Allegion plc issued a press release on July 23, 2026 announcing its second quarter 2026 financial results, including net revenues of $1,151.5 million (up 12.7%), net earnings of $184.6 million ($2.15 EPS, up 16.2%), and adjusted EPS of $2.40 (up 17.6%). The company also raised its full-year 2026 outlook for revenue and adjusted EPS. This is a standard quarterly earnings disclosure with material financial metrics and forward guidance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-23
Item 2.02
Knowles Corporation issued a press release on July 23, 2026 announcing Q2 2026 financial results for the quarter ended June 30, 2026, including revenues of $166.8 million (14% YoY growth), diluted EPS of $0.21, and non-GAAP diluted EPS of $0.33. The filing includes detailed consolidated statements of earnings, reconciliations to non-GAAP measures, and forward guidance for Q3 2026, all typical of a quarterly earnings release disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-23
Item 2.02
Summit Therapeutics issued a press release on July 23, 2026 announcing Q2 2026 financial results and operational progress, including GAAP and Non-GAAP operating expenses, net loss, cash position of $690.7 million, and significant clinical progress on ivonescimab including positive HARMONi-6 overall survival data.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-23
Item 2.02
Kearny Financial Corp. disclosed fourth quarter and fiscal year 2026 financial results, reporting net income of $7.2 million for Q4 and $36.3 million for the full year ended June 30, 2026, along with detailed financial metrics and strategic achievements.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-23
Item 8.01
The Board of Directors declared a quarterly cash dividend of $0.11 per share, payable on August 26, 2026, to stockholders of record as of August 12, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-23
Item 2.02
Business First Bancshares issued a press release on July 23, 2026, announcing unaudited financial results for Q2 2026, including net income of $22.8 million ($0.70 per diluted share), net interest margin expansion to 3.73%, and improved asset quality metrics.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-23
Item 5.02
The filing discloses the appointment of Andre Mintz as a new director to CS Disco's board, effective immediately on July 22, 2026, increasing board size from eight to nine members. The disclosure includes his background, independence determination, and compensation arrangements (initial $300,000 RSU grant plus $35,000 annual cash retainer). This is a material governance event affecting board composition and investor assessment of the company's leadership.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-23
Item 2.02
Comcast issued a press release on July 23, 2026 reporting results of operations for the three and six months ended June 30, 2026, with detailed consolidated financial results including revenue, net income, adjusted EBITDA, EPS, free cash flow, and segment performance metrics. This is a standard quarterly earnings disclosure attached as Exhibit 99.1, typical of Item 2.02 filings.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-07-23
Item 2.02
This is a standard quarterly earnings release for Q2 2026 (quarter ended June 28, 2026) disclosing sales of $20.1 billion (11% increase), net earnings of $1.8 billion ($7.94 per share), and updated full-year 2026 financial guidance. The news release is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures. Material to investors as it reports significant financial results and raises full-year guidance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-23
Item 2.02
Lazard issued a press release on July 23, 2026, announcing financial results for the second quarter and first half of 2026, including net revenue of $808 million and $1,564 million respectively, net income of $5 million and $106 million respectively, and diluted EPS of $0.03 and $0.94 respectively. This is a standard quarterly earnings disclosure furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the canonical form for earnings releases.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-23
Item 2.02
The filing discloses quarterly and year-to-date financial results for the three and six months ended June 30, 2026, presented in a press release format (Exhibit 99.1). The disclosure includes net sales of $216 million (28% increase), net income of $49 million, and adjusted EBITDA of $67 million, along with raised full-year 2026 guidance. This is a standard earnings release under Item 2.02 that would materially affect a reasonable investor's assessment of the company's financial performance and outlook.
View raw filing on EDGAR →